Cite this article as:

Buynitskaya E. S. Managerial Aspect in Activity of Pharmaceutical Companies. Izv. Saratov Univ. (N. S.), Ser. Economics. Management. Law, 2015, vol. 15, iss. 3, pp. 303-? DOI:


Managerial Aspect in Activity of Pharmaceutical Companies

The article explains the use of the project approach in
the management of innovative activity of pharmaceutical companies
and determining the cost-effectiveness of investments in innovation
activities of pharmaceutical companies. Theoretical analysis. The
activity of pharmaceutical companies is increasingly taking the form
of projects. This is primarily due to the necessity of standardization
the most important aspects of corporate management activities of
pharmaceutical companies. In the conditions of high competitive
environment in order to ensure the survival of the pharmaceutical
enterprises in these conditions, it is necessary to realize the innovation
activity under condition of using the system of innovation project
management. The necessity of creating the system of innovation
project management at pharmaceutical manufactory is specify of
development of pharmaceutical market, which needs in fast response.
That’s why in order to achieve the effectiveness of using resources,
observance of time of implementation of management decisions
necessary to ensure optimum interaction processes (or all activities)
under the conditions of each project. According to the author, in the
project management system, it is expedient to introduce evaluation
of innovative projects based on the concept of real options. Results.
Revealed the value of real options approach with a high degree of
uncertainty in terms of functioning of the company and the possibility
of managerial influence on it. It is appeared the possibility and right
to change strategy


1. Luchkin V. Azbuka upravlenija proektami vnedrenija
innovacij [The ABC project management innovation].
Den’gi i tehnologii [Money and technologies], 2006,
no. 5, pp. 34–37.
2. Upravlenie proektom: Osnovy proektnogo upravlenija
[Manage the project. Fundamentals of project management.
Textbook. 3rd ed. Ed. by M. L. Razu.]. Moscow,
KNORUS Publ., 2010. 760 p.
3. GOST R ISO 21500 – 2014 «Rukovodstvo po proektnomu
menedzhmentu» (GOST R ISO 21500 – 2014 «Guidance
on project management»). Available at: http://protect.
&month=3&year=2015&search=&id=198457 (accessed
22 April 2015).
4. Onis’ko O. V. Dolgaja doroga k GMP [The long road to
GMP]. Mister Blister, 2006, no. 12, pp. 9–10.

5. Mazur I. I., Shapiro V. D. (ed.). Upravlenie proektami
[Project Management. 6th ed., ster.]. Moscow, Omega-L
Publ., 2010. 960 p.
6. Limitovskij M. A. Investicionnye proekty i real’nye opciony
na razvivajushhihsja rynkah [Investment projects
and real options in emerging markets. 5th ed., reslave.
and additional]. Moscow, Jurajt Publ., 2014. 486 p.
7. Brealey R., Myers S., Allen F. Principles of Corporate
Finance. New York, McGraw-Hill Education, 2014. 976 p.
8. Copeland T., Koller T., Murrin J. Valuation: Measuring
and Managing the Value of Companies. 5th ed. New York,
John Wiley & Sons, 2010. 840 p.
9. Rogova E. M., Jarygin A. I., Sirik E. S. Venchurnye investicii
v biofarmacevticheskie kompanii: podhod k ocenke
jeffektivnosti proektov [Venture capital investments in
pharmaceutical companies: an approach to evaluating
the effectiveness of projects]. Innovacii [Innovations],
2012, no. 9 (167), pp. 39–47.

Short Text (PDF):